Buscar
Mostrando ítems 1-10 de 77
COST-EFFECTIVENESS ANALYSIS OF CISPLATIN-BASED CHEMORADIATION TO TREAT PATIENTS WITH UNRESECTABLE, NONMETASTATIC HEAD AND NECK CANCER IN BRAZIL
(WILEY-BLACKWELL, 2011)
Background. The purpose of this study was to analyze the cost-effectiveness of cisplatin-based chemoradiation compared to radiation therapy (RT) alone to treat patients with advanced head and neck cancer in Brazil. Methods. ...
Lymph Node Size in Rectal Cancer Following Neoadjuvant Chemoradiation-Can We Rely on Radiologic Nodal Staging After Chemoradiation?
(LIPPINCOTT WILLIAMS & WILKINS, 2009)
OBJECTIVES: Local excision is currently being considered as an alternative strategy for ypT0-2 rectal cancer. However, patient selection is crucial to rule out nodal disease and is performed by radiologic studies that ...
Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal Cancer
(W B SAUNDERS CO-ELSEVIER INC, 2010)
Multimodality treatment of rectal cancer, with the combination of radiation therapy, chemotherapy, and surgery has become the preferred approach to locally advanced rectal cancer The use of neoadjuvant chemoradiation therapy ...
Transanal Endoscopic Microsurgery for Residual Rectal Cancer After Neoadjuvant Chemoradiation Therapy Is Associated With Significant Immediate Pain and Hospital Readmission Rates
(LIPPINCOTT WILLIAMS & WILKINS, 2011)
BACKGROUND: Transanal endoscopic microsurgery may represent appropriate diagnostic and therapeutic procedure in selected patients with distal rectal cancer following neoadjuvant chemoradiation. Even though this procedure ...
ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
(SPANDIDOS PUBL LTD, 2011)
Adjuvant cisplatin-based chemoradiation improves survival in HNSCC patients presenting with risk features. ERCC1 (excision repair cross-complementation group 1) is associated with resistance to chemo- and radiation therapy ...
Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?
(WILEY-BLACKWELLMALDEN, 2013-08-02)
Aim The study aimed to determine the value of postchemoradiation biopsies, performed after significant tumour downsizing following neoadjuvant therapy, in predicting complete tumour regression in patients with distal rectal ...
Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization
(LIPPINCOTT WILLIAMS & WILKINS, 2010)
BACKGROUND: Complete tumor regression may develop after neoadjuvant chemoradiation therapy for distal rectal cancer. Studies have suggested that selected patients with complete clinical response may avoid radical surgery ...
Total pelvic exenteration for locally advanced rectal tumors. Experience in 10 patients Exenteración pélvica total por cáncer primario del recto: Resultados inmediatos y alejados
(Sociedad de Cirujanos de Chile, 2016)
© 2016 Sociedad de Cirujanos de Chile. Aim: To report the results of total pelvic exenteration (TPE) in patients with locally advanced primary rectal tumors. Material and method: We report 10 patients with stage 4 rectal ...
The impact of mindfulness-based interventions on the wellbeing of cervical cancer patients on chemoradiotherapy
(Universidade Federal de Minas GeraisBrasilMED - DEPARTAMENTO DE CLÍNICA MÉDICAMED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIAUFMG, 2017-04-24)